GlassScriptPhysician profile
Doreen A Moser
NPI 1194721944
$8,247.19
in general payments reported to CMS, 2019-2025
33 companies · $4,471 in 2025
The $4,471 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $115 · 2021: $298 · 2022: $1,518 · 2023: $451 · 2024: $1,259 · 2025: $4,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $981.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $5,200.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $1,077.25 | 2022 | |
| Abbvie INC. | $443.83 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $304.54 | 2021-2025 | |
| Millicent US INC | $95.56 | 2020-2025 | Intrarosa, Femlyv |
| Teleflex LLC | $89.96 | 2019 | |
| Axonics, INC. | $81.65 | 2022-2023 | Bulkamid |
| Shield Therapeutics INC | $81.18 | 2024 | |
| Myovant Sciences INC. | $79.72 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $68.64 | 2023-2025 | Exparel |
| Biogen, INC. | $56.06 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $50.96 | 2021-2022 | |
| Evofem Biosciences, INC. | $47.02 | 2021 | |
| Astellas Pharma US INC | $46.91 | 2024-2025 | Veozah |
| Organon LLC | $43.49 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $41.64 | 2024 | |
| Virtus Pharmaceuticals LLC | $40.75 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $37.62 | 2022-2023 | Vivjoa |
| Aspira Women'S Health INC | $36.79 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $36.46 | 2021-2025 | Slynd |
| Molnlycke Health Care US, LLC | $32.43 | 2024 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Exact Sciences Corporation | $29.40 | 2025 | The Cologuard Plus Collection Kit |
| Lupin INC. | $29.14 | 2019 | |
| Therapeuticsmd, INC. | $28.30 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.77 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.55 | 2023 | Vpriv |
| Channel Medsystems, INC. | $21.49 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $20.43 | 2021 | |
| Allergan, INC. | $19.29 | 2020 | |
| Minerva Surgical, INC | $15.49 | 2023 | |
| Mylan Pharmaceuticals INC. | $14.95 | 2020 | |
| Avion Pharmaceuticals | $14.82 | 2022 | |
| Bausch Health US, LLC | $14.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doreen Moser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.